Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001016504-16-000022
Filing Date
2016-05-13
Accepted
2016-05-13 15:48:41
Documents
55
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 inb10q_20160331.htm 10-Q 510249
2 exhibit31_1.htm EX-31.1 10809
3 exhibit31_2.htm EX-31.2 10788
4 exhibit32_1.htm EX-32.1 4388
5 exhibit32_2.htm EX-32.2 4393
  Complete submission text file 0001016504-16-000022.txt   4189719

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT inbp-20160331.xml EX-101.INS 998229
7 XBRL TAXONOMY EXTENSION SCHEMA inbp-20160331.xsd EX-101.SCH 43350
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inbp-20160331_cal.xml EX-101.CAL 38795
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20160331_def.xml EX-101.DEF 306259
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20160331_lab.xml EX-101.LAB 260543
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20160331_pre.xml EX-101.PRE 321764
Mailing Address 225 LONG AVENUE PO BOX 278 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE PO BOX 278 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

EIN.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31668 | Film No.: 161648143
SIC: 2834 Pharmaceutical Preparations